Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway is a research paper published in Oncotarget (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: P20 GM103548
NIGMS NIH HHS
Grant: P20 GM103620
NCI NIH HHS
Grant: P30 CA042014
Keywords